CARGO Therapeutics Enters Material Definitive Agreement

Cargo Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyCargo Therapeutics, Inc.
Form Type8-K
Filed DateJul 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, filing

TL;DR

CARGO Therapeutics signed a big deal on 7/7/25. Details to follow.

AI Summary

On July 7, 2025, CARGO Therapeutics, Inc. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 835 Industrial Road, Suite 400, San Carlos, California.

Why It Matters

This filing indicates a significant new contract or partnership for CARGO Therapeutics, which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, but the specifics of the agreement and its potential impact are not detailed, creating uncertainty.

Key Numbers

  • 001-41859 — SEC File Number (Identifies the company's filing with the SEC.)
  • 84-4080422 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • CARGO Therapeutics, Inc. (company) — Registrant
  • July 7, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • 835 Industrial Road Suite 400 (address) — Principal Executive Offices
  • San Carlos, California (location) — City and State of Principal Executive Offices
  • 94070 (zip_code) — Zip Code of Principal Executive Offices
  • (650) 499-8950 (phone_number) — Registrant's Telephone Number

FAQ

What type of material definitive agreement did CARGO Therapeutics, Inc. enter into?

The filing states that CARGO Therapeutics, Inc. entered into a material definitive agreement on July 7, 2025, but does not specify the nature of the agreement.

What is the primary business of CARGO Therapeutics, Inc.?

CARGO Therapeutics, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].

Where are CARGO Therapeutics, Inc.'s principal executive offices located?

The principal executive offices of CARGO Therapeutics, Inc. are located at 835 Industrial Road, Suite 400, San Carlos, California, 94070.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on July 7, 2025.

What is the fiscal year end for CARGO Therapeutics, Inc.?

The fiscal year end for CARGO Therapeutics, Inc. is December 31 (1231).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding CARGO Therapeutics, Inc..

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.